The collaboration is focused on the development of a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption. PharmaNova’s NovaSperse nanoparticle technology will be leveraged
Presenting a set of recommendations to the country’s union commerce ministry, the domestic makers claimed that unrestricted imports have threatened the survival of their businesses, as reported by
NICE chief executive Sir Andrew Dillon said there is evidence to suggest that bosutinib was considered clinically effective for the treatment of CML. However, the manufacturer had provided
By binding to inert resins, the enzymes are immobilized facilitating separation from a reaction mixture and allowing for use under diverse conditions and re-use at a commercial scale.
The Swiss agency for therapeutic products, Swissmedic, cleared tofacitinib 5mg and 10mg twice-daily (BID) as monotherapy or combination therapy along with a disease modifying non-biologic antirheumatic agent (DMARD)
These supplements help in improving the metabolism and restore the body’s ability to naturally regulate weight. Vitality Health & Wellness Dr Rapkin said that the natural, nutritional supplements
Planning to raise the financing through a private equity funding arrangement, the company is already in discussions with some financial institutional players. Roselabs executive Zameer Agarwal was quoted
The new plant, which has been inspected by the Medicines and Healthcare products Regulatory Agency (MHRA), is intended to provide access to clinical manufacturing capabilities for all the
The new formula is designed to boost libido, increase lean mass, decrease body fat, increase stamina, and improve mood and energy production, claimed the company. VH Nutrition company
According to the deal, Harvard research is aimed at the discovery, evaluation and development of engineered recombinant botulinum toxins that will be funded by Ipsen for a minimum
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.